Catalyst Wire Dossier Catalyst Wire Dossier

Ambroxol lozenges 20 mg

ambroxol · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ambroxol lozenges 20 mg, covering 2013-10-29 to 2019-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore Throat [Phase 3]

See pricing